UnknownNCT02778607
PROgressive Supranuclear Palsy CorTico-Basal Syndrome Multiple System Atrophy Longitudinal Study UK
Studying Rare parkinsonian syndrome due to neurodegenerative disease
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- University College, London
- Principal Investigator
- Huw Morris, PhD, FRCPUniversity College, London
- Enrollment
- 900 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2014 – 2023
Study locations (1)
- University College London Hospitals, London, United Kingdom
Collaborators
University of Cambridge · University of Oxford · University of Manchester · Newcastle University · University of Sussex · Royal Gwent Hospital
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT02778607 on ClinicalTrials.govOther trials for Rare parkinsonian syndrome due to neurodegenerative disease
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT06785948tDCS Effect on Psychotic Symptoms in Dementia With Lewy Bodies (DLB), and Impacts on Caregiver BurdenAssociation de Recherche Bibliographique pour les Neurosciences
- RECRUITINGNANCT06072105Medical Decision Making in Multiple System AtrophyMedical University Innsbruck
- ACTIVE NOT RECRUITINGNCT05453058Observational Study in Multiple System AtrophyH. Lundbeck A/S
- RECRUITINGNANCT04250493Insulin Resistance in Multiple System AtrophyUniversity Hospital, Bordeaux
- RECRUITINGNCT02194816Modifiable Variables in Parkinsonism (MVP)Bastyr University
See all trials for Rare parkinsonian syndrome due to neurodegenerative disease →